Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
Daniel A. Ryskamp, Svetlana A. Korban, Vladimir Zhemkov, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Mitochondria Associated Membranes (MAMs): Architecture and physiopathological role
Lucia Barazzuol, Flavia Giamogante, Tito Calì
Cell Calcium (2021) Vol. 94, pp. 102343-102343
Closed Access | Times Cited: 104
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
Amir Ajoolabady, Daolin Tang, Guido Kroemer, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 2, pp. 190-205
Open Access | Times Cited: 77
Advancements in the development of multi-target directed ligands for the treatment of Alzheimer’s disease
Naveen Kumar, Vijay Kumar, Piyush Anand, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 61, pp. 116742-116742
Closed Access | Times Cited: 70
Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations
Samuele Maramai, Mohamed Benchekroun, Moustafa T. Gabr, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-27
Open Access | Times Cited: 90
Sigmar1’s Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology
Richa Aishwarya, Chowdhury S. Abdullah, Mahboob Morshed, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 79
Recent advances in management of COVID-19: A review
Soraya Mouffak, Qamar Shubbar, Ekram Saleh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112107-112107
Open Access | Times Cited: 76
Multipronged diagnostic and therapeutic strategies for Alzheimer's disease
Madhu Ramesh, Thimmaiah Govindaraju
Chemical Science (2022) Vol. 13, Iss. 46, pp. 13657-13689
Open Access | Times Cited: 52
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Andrea Mastinu, Margrate Anyanwu, Marinella Carone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1329-1329
Open Access | Times Cited: 37
Overview of Sigma-1R Subcellular Specific Biological Functions and Role in Neuroprotection
Véronik Lachance, Sara-Maude Bélanger, Célia Hay, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1971-1971
Open Access | Times Cited: 25
N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk
Dan Cheng, Zhuogui Lei, Kin Chu, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
Multi-target drugs for Alzheimer's disease
Bengisu Turgutalp, Çağhan Kızıl
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 628-638
Closed Access | Times Cited: 14
Sigma-1 Receptor Specific Biological Functions, Protective Role, and Therapeutic Potential in Cardiovascular Diseases
Ahmed Al‐Maamari, Marwa Sultan, Tao Zhang, et al.
Cardiovascular Toxicology (2025)
Closed Access | Times Cited: 1
The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity
Shefali Gupta, Raj K. Bhatnagar, Dinesh Gupta, et al.
Psychopharmacology (2025)
Closed Access | Times Cited: 1
Sigma-1 Receptor Agonists Induce Oxidative Stress in Mitochondria and Enhance Complex I Activity in Physiological Condition but Protect Against Pathological Oxidative Stress
Nino Goguadze, Elene Zhuravliova, Didier Morin, et al.
Neurotoxicity Research (2017) Vol. 35, Iss. 1, pp. 1-18
Closed Access | Times Cited: 84
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases
Na Ye, Wangzhi Qin, Sheng Tian, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15187-15217
Closed Access | Times Cited: 65
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
Urszula Kozłowska, Charles D. Nichols, Kalina Wiatr, et al.
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 89-108
Open Access | Times Cited: 55
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
Wojciech Danysz, Andrzej Dekundy, Astrid Scheschonka, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 2, pp. 127-169
Open Access | Times Cited: 53
The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains
Vladimir Zhemkov, Jonathon A. Ditlev, Wan-Ru Lee, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 53
Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function
Chowdhury S. Abdullah, Richa Aishwarya, Shafiul Alam, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 51
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective
Antonino N. Fallica, Valeria Pittalà, Maria Modica, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7926-7962
Open Access | Times Cited: 50
Axonal generation of amyloid-β from palmitoylated APP in mitochondria-associated endoplasmic reticulum membranes
Raja Bhattacharyya, Sophia E. Black, Madhura S. Lotlikar, et al.
Cell Reports (2021) Vol. 35, Iss. 7, pp. 109134-109134
Open Access | Times Cited: 46
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
Steven A. Barker
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1749-1763
Open Access | Times Cited: 38
Endoplasmic Reticulum-Mitochondria Contacts Modulate Reactive Oxygen Species-Mediated Signaling and Oxidative Stress in Brain Disorders: The Key Role of Sigma-1 Receptor
Rosa Resende, Tânia Fernandes, Ana Catarina Pereira, et al.
Antioxidants and Redox Signaling (2022) Vol. 37, Iss. 10-12, pp. 758-780
Closed Access | Times Cited: 38
Impact of ER Stress and ER-Mitochondrial Crosstalk in Huntington’s Disease
Shuvadeep Maity, Pragya Komal, Vaishali Kumar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 780-780
Open Access | Times Cited: 35
Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development
Peng Ren, Jingya Wang, Nanxi Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top